BridgeBio Oncology Therapeutics BBOT Income Statement (2023-2026)

NASDAQ BBOT
$2.56 +0.36 (+16.36%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

BridgeBio Oncology Therapeutics Quarterly Income Statement

Periods 12 quarters
Latest Sep 2026

BridgeBio Oncology Therapeutics reported net income of -$37.49M for the quarter ended Sep 2026. This income statement covers 12 quarters of results from Dec 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Cost of RevenueCost of Rev 0.07M
Operating items
Research & DevelopmentR&D 17.89M19.54M20.64M27.44M35.05M38.07M39.80M49.23M29.59M
Share-based Compensation (IS)Stock Comp. -0.04M-0.08M-0.08M-0.08M-0.06M-0.04M
Selling, General & AdministrativeSG&A 0.07M0.15M1.78M2.34M2.50M2.66M14.13M5.33M6.38M10.96M7.90M
Operating ExpensesOpex 0.07M0.15M19.66M21.88M23.14M30.09M49.18M43.41M46.18M60.19M37.49M
Operating IncomeOp. Inc -0.07M-0.15M-19.66M-21.88M-23.14M-30.09M-49.18M-43.41M-46.18M-60.19M-37.49M
Non-operating items
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales -0.06M-0.16M-0.14M-1.00M0.02M
Interest & Investment IncomeInt & Inv Inc 1.21M2.44M2.55M2.25M1.99M2.07M
Other Non Operating IncomeOther Non Op Inc. 0.00M-0.01M-0.03M0.01M-0.09M-0.01M-0.04M
Non Operating IncomeNon Op. Inc. 1.17M2.36M2.34M2.19M1.08M1.66M4.42M4.61M4.07M3.73M3.31M
Net income details
EBIT -0.07M-0.15M-19.66M-21.88M-23.14M-30.09M-49.18M-43.41M-46.18M-60.19M-37.49M
EBT 1.14M2.29M-17.11M-19.63M-21.15M-28.02M-49.18M-43.41M-46.18M-60.19M-37.49M
Income After Tax 1.14M2.29M-17.11M-19.63M-21.15M-28.02M-49.18M-43.41M-46.18M-60.19M-37.49M
Income from Continuing OperationsIncome (Continuing) 1.14M2.29M-17.11M-19.63M-21.15M-28.02M-49.18M-43.41M-46.18M-60.19M-37.49M
Consolidated Net IncomeConsol Net Inc. 1.14M2.29M-17.11M-19.63M-21.15M-28.02M-49.18M-43.41M-46.18M-60.19M-37.49M
Income towards Parent CompanyParent Net Inc -15.44M-21.82M-17.32M-19.70M-22.06M-28.44M-44.80M-38.80M-42.11M-56.45M-34.20M
Net Income towards Common StockholdersNet Income 1.10M2.21M2.33M1.95M-0.49M0.92M-44.80M-38.80M-42.11M-56.45M-34.20M
Additional items
EPS (Basic) 0.080.090.100.09-0.030.04-1.03-1.25-1.35-0.71-0.43
EPS (Diluted) 0.080.090.100.09-0.030.05-1.03-1.25-1.35-0.71-0.43
Shares Outstanding 4.00M14.19M23.51M23.51M21.16M18.91M23.51M43.49M31.14M31.14M80.05M80.18M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 4.00M14.47M23.51M23.51M21.24M18.91M18.91M43.49M31.14M31.14M80.05M80.18M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 16.12M35.56M41.50M41.50M36.90M41.47M43.98M43.49M43.98M80.12M80.25M
EBITDA -21.83M-23.08M-29.88M-48.97M-43.20M-45.97M-59.97M-37.27M

BridgeBio Oncology Therapeutics Income Statement API

Pull BridgeBio Oncology Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BBOT&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY